Jan 1, 1999 - ...SIDNEY C. SMITH, JR., M.D., University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina Am Fam Physician. 1999 Jan 1;59(1):35-. During the past decade, several landmark trials have confirmed the benefits of angiotensin converting enzyme (ACE)...
American Family Physician : Editorials
Oct 15, 2016 - ACE inhibitors reduce the risk of progression to macroalbuminuria in normotensive patients with microalbuminuria and type 1 diabetes mellitus.
American Family Physician : FPIN's Clinical Inquiries
Jun 1, 1999 - Angiotensin-II receptor antagonists (or blockers) are a newer class of antihypertensive agents. These drugs are selective for angiotensin II (type 1 receptor); unlike angiotensin-converting enzyme inhibitors, they do not inhibit bradykinin metabolism or enhance prostaglandin synthesis. ...
American Family Physician : Article
Jan 1, 2018 - In this post-hoc analysis of the previously published SPRINT trial, lowering the systolic blood pressure of patients who are at increased risk of cardiovascular events (average age = 66 years) will decrease their risk of cardiovascular disease but increase their likelihood of developing...
American Family Physician : POEMs
navigate_before 1 navigate_next